SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What makes MOG an absolute game-changer is our relentless dedication to memes and viral brilliance! We don't settle for mediocrity; we plunge into the realm of sheer awesomeness! Our community is a powerhouse of meme warriors, unleashing an unstoppable onslaught of viral memes that'll leave you in awe and stitches!  We're not here to play games; we're here to dominate! MOG is all about pushing the boundaries, smashing through barriers, and leaving our competitors eating our dust! Our passion for humor burns like an inferno, and we won't rest until the entire internet bows down to our meme supremacy!  And our community? It's a brotherhood, an unyielding powerhouse of support and camaraderie! When you're part of MOG, you're part of an unstoppable force, a family forged by the fire of meme revolution!  So, if you're ready to be part of the most intense, mind-bending memecoin movement ever conceived, then buckle up, strap in, and brace yourself! MOG is here to claim the throne, and we're taking no prisoners! Get ready to witness meme history in the making!

 MOG Coin

MOG Coin is currently trending due to swirling speculation around a potential Binance listing and an ETF application, driving significant community discussion. Investors are sharply divided, with many aggressively buying, anticipating a major rally and "altcoin season," while an equally vocal group passionately labels it a "scam" and warns against participation given past performance.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco Systems is generating significant market buzz, propelled by robust demand for its AI infrastructure solutions and strategic partnerships. The community is actively discussing the stock's recent ascent to levels not observed in decades, positioning it as a key player in the ongoing technological evolution and a focal point for valuation debates.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata Inc is heavily discussed due to anticipation of a significant strategic partnership announcement, possibly with a major government or military contractor, which the CEO hinted at before year-end and is expected to be a "game-changer" for its AI data training business. While many bulls foresee substantial rallies driven by technical indicators and strong fundamentals, a vocal skeptical faction expresses frustration over past unfulfilled promises and questions the immediate impact of any news amid low trading volume and broader AI market sentiment.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop continues to ignite passionate debate within its community, with many speculating on the impact of the Japanese Yen Carry Trade on deep short positions and perceived market manipulation. Despite mainstream skepticism, dedicated 'Apes' remain focused on the stock's underlying fundamental performance and the widely held belief that 'shorts never closed', anticipating a significant market event.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is trending due to ongoing excitement surrounding its advanced on-chain AI capabilities (like Caffeine AI) and Chain Fusion upgrades, alongside recent discussions about the Menese Protocol. The community is sharply divided between those who view its unique decentralized cloud architecture and Bitcoin Layer 2 potential as massively undervalued long-term, and others who see recent price volatility as indicative of a pump-and-dump or market manipulation.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is trending with highly polarized sentiment as the community debates its recent price declines, with many calling it a 'scam' or 'dead' and suggesting alternatives. However, strong counter-arguments highlight upcoming catalysts such as the Midnight sidechain launch and potential USDC integration, leading long-term holders to view current levels as an accumulation opportunity despite perceived market manipulation.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is actively trending following its recent earnings report, showcasing robust growth in its automotive and IoT segments while strategically expanding into AI data center solutions. This diversification is seen as crucial for future revenue growth beyond its core smartphone business amid evolving competition. The community is buzzing with debate, as many bulls highlight the company's undervaluation and AI potential, while bears express caution over a significant one-time tax charge and potential shifts in key client relationships.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

The VanEck Gold Miners ETF ($GDX) is currently trending, with the community actively highlighting bullish technical setups and Elliott Wave patterns that suggest significant upside potential. Investors are discussing the sector as an important hedge against ongoing macroeconomic concerns, including inflation, extensive government debt, and perceived currency debasement. This sentiment is further amplified by calls for the gold mining complex to catch up to gold's sustained strength, potentially leading to a short squeeze.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently trending following a robust Q1 earnings beat and elevated full-year guidance, solidifying its reputation as a MedTech powerhouse. The community is actively discussing the significant clinical successes and regulatory advancements of its FARAPULSE PFA system, alongside strategic acquisitions and global expansion, particularly into emerging markets. Investors see BSX as a sector leader driving impressive growth through innovation and market penetration.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending due to contrasting developments impacting its core business and future growth. Recent setbacks in its oncology pipeline, including the domvanalimab program, and CVS's decision not to cover its new HIV prevention drug, Yeztugo, are weighing on sentiment. However, the community is also focusing on positive Phase 3 HIV data and extended patent exclusivity for Biktarvy until 2036, fueling debates around GILD's strategic M&A moves and its balance of strong existing products with an evolving pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Spero Therapeutics (NASDAQ:SPRO) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen raised Spero Therapeutics from a "hold" rating to a "buy" rating in a research report on Sunday...

Spero Therapeutics (NASDAQ:SPRO) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded Spero Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...

Wall Street Zen raised Spero Therapeutics from a "hold" rating to a "buy" rating in a research note on Friday...

Spero Therapeutics (NASDAQ:SPRO) Shares Pass Above 200 Day Moving Average on Insider Selling

Spero Therapeutics (NASDAQ:SPRO) Shares Cross Above Two Hundred Day Moving Average After Insider Selling...

Spero Therapeutics (NASDAQ:SPRO) Issues Earnings Results, Beats Estimates By $0.12 EPS

Spero Therapeutics (NASDAQ:SPRO - Get Free Report) announced its earnings results on Thursday. The company reported ($0.13) EPS for the quarter, topping analysts' consensus estimates of ($0.25) by...

Spero Therapeutics (NASDAQ:SPRO) Insider Esther Rajavelu Sells 40,270 Shares

Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) insider Esther Rajavelu sold 40,270 shares of the stock in a transaction on Friday, November 7th. The shares were sold at an average price of...

Spero Therapeutics (NASDAQ:SPRO) Insider Sells $95,439.90 in Stock

Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) insider Esther Rajavelu sold 40,270 shares of the business's stock in a transaction that occurred on Friday, November 7th. The stock was sold...

Best Momentum Stock to Buy for October 10th

SPRO made it to the Zacks Rank #1 (Strong Buy) momentum stock list on October 10, 2025.

Bayer Reports Positive Data on Cell Therapy for Parkinson's Disease 

BAYRY's subsidiary BlueRock reports 36-month data showing its Parkinson's therapy bemdaneprocel remains safe and effective in easing motor symptoms.

Down 17.7% in 4 Weeks, Here's Why Spero Therapeutics (SPRO) Looks Ripe for a Turnaround 

The heavy selling pressure might have exhausted for Spero Therapeutics (SPRO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.

SPRO
Spero Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SPRO News

SPROSpero Therapeutics Inc